Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A nano-luciferase expressing human coronavirus OC43 for countermeasure development.
Virus Res. 2024 Jan 2;339:199286. doi: 10.1016/j.virusres.2023.199286. Epub 2023 Dec 5.
Virus Res. 2024.
PMID: 38016504
Free PMC article.
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential.
Martinez DR, Moreira FR, Zweigart MR, Gully KL, De la Cruz G, Brown AJ, Adams LE, Catanzaro N, Yount B, Baric TJ, Mallory ML, Conrad H, May SR, Dong S, Scobey DT, Montgomery SA, Perry J, Babusis D, Barrett KT, Nguyen AH, Nguyen AQ, Kalla R, Bannister R, Bilello JP, Feng JY, Cihlar T, Baric RS, Mackman RL, Schäfer A, Sheahan TP.
Martinez DR, et al. Among authors: baric tj.
bioRxiv [Preprint]. 2023 Jun 28:2023.06.27.546784. doi: 10.1101/2023.06.27.546784.
bioRxiv. 2023.
PMID: 37425890
Free PMC article.
Preprint.
Item in Clipboard
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.
Young E, Yount B, Pantoja P, Henein S, Meganck RM, McBride J, Munt JE, Baric TJ, Zhu D, Scobey T, Dong S, Tse LV, Martinez MI, Burgos AG, Graham RL, White L, DeSilva A, Sariol CA, Baric RS.
Young E, et al. Among authors: baric tj.
Nat Commun. 2023 Mar 13;14(1):1371. doi: 10.1038/s41467-023-36702-x.
Nat Commun. 2023.
PMID: 36914616
Free PMC article.
Item in Clipboard
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.
Young E, Carnahan RH, Andrade DV, Kose N, Nargi RS, Fritch EJ, Munt JE, Doyle MP, White L, Baric TJ, Stoops M, DeSilva A, Tse LV, Martinez DR, Zhu D, Metz S, Wong MP, Espinosa DA, Montoya M, Biering SB, Sukulpolvi-Petty S, Kuan G, Balmaseda A, Diamond MS, Harris E, Crowe JE Jr, Baric RS.
Young E, et al. Among authors: baric tj.
Cell Host Microbe. 2020 May 13;27(5):710-724.e7. doi: 10.1016/j.chom.2020.04.007.
Cell Host Microbe. 2020.
PMID: 32407709
Free PMC article.
Item in Clipboard
Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN, Young EF, Baric TJ, Yount BL, Metz SW, Begley MC, de Silva AM, Baric RS.
Gallichotte EN, et al. Among authors: baric tj.
mBio. 2019 Sep 17;10(5):e01485-19. doi: 10.1128/mBio.01485-19.
mBio. 2019.
PMID: 31530669
Free PMC article.
Item in Clipboard
Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization.
Gallichotte EN, Baric TJ, Nivarthi U, Delacruz MJ, Graham R, Widman DG, Yount BL, Durbin AP, Whitehead SS, de Silva AM, Baric RS.
Gallichotte EN, et al. Among authors: baric tj.
Cell Rep. 2018 Oct 30;25(5):1214-1224. doi: 10.1016/j.celrep.2018.10.006.
Cell Rep. 2018.
PMID: 30380413
Free PMC article.
Item in Clipboard
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
Gallichotte EN, Baric TJ, Yount BL Jr, Widman DG, Durbin A, Whitehead S, Baric RS, de Silva AM.
Gallichotte EN, et al. Among authors: baric tj.
PLoS Pathog. 2018 Feb 26;14(2):e1006934. doi: 10.1371/journal.ppat.1006934. eCollection 2018 Feb.
PLoS Pathog. 2018.
PMID: 29481552
Free PMC article.
Item in Clipboard
Cite
Cite